Qinghai Spring Medicinal Resources Technology Co Ltd (600381) — Strategic Asset Allocation Index
Qinghai Spring Medicinal Resources Technology Co Ltd (600381) has a Strategic Asset Allocation Index of 20.3% as of June 2023. Strategic assets (PP&E of CN¥300.72 Million plus long-term investments of CN¥-) total CN¥300.72 Million, measured against net assets of CN¥1.48 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Qinghai Spring Medicinal Resources Techn (600381) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Qinghai Spring Medicinal Resources Technology Co Ltd Strategic Asset Allocation Index (2000–2022)
This chart shows how Qinghai Spring Medicinal Resources Technology Co Ltd's Strategic Asset Allocation Index has evolved across 18 annual periods from 2000 to 2022. As of June 2023, the index stands at 20.3%, representing strategic assets of CN¥300.72 Million against net assets of CN¥1.48 Billion CNY. See how financially flexible is Qinghai Spring Medicinal Resources Techn to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Qinghai Spring Medicinal Resources Technology Co Ltd (2000–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Qinghai Spring Medicinal Resources Technology Co Ltd from 2000 to 2022, covering 18 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Qinghai Spring Medicinal Resources Techn market capitalisation.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 18.3% | CN¥281.18 Million | CN¥281.18 Million | CN¥- | CN¥1.53 Billion | ▲ +2.0 pp |
| 2021 | 16.3% | CN¥296.92 Million | CN¥296.92 Million | CN¥- | CN¥1.82 Billion | ▲ +1.1 pp |
| 2020 | 15.2% | CN¥314.39 Million | CN¥314.39 Million | CN¥- | CN¥2.07 Billion | ▲ +9.8 pp |
| 2019 | 5.4% | CN¥129.50 Million | CN¥129.50 Million | CN¥- | CN¥2.39 Billion | ▼ -15.7 pp |
| 2018 | 21.1% | CN¥503.50 Million | CN¥134.80 Million | CN¥368.69 Million | CN¥2.38 Billion | ▲ +2.7 pp |
| 2017 | 18.4% | CN¥427.81 Million | CN¥100.64 Million | CN¥327.17 Million | CN¥2.32 Billion | ▲ +11.5 pp |
| 2016 | 6.9% | CN¥138.19 Million | CN¥98.19 Million | CN¥40.00 Million | CN¥2.00 Billion | ▲ +1.4 pp |
| 2015 | 5.5% | CN¥96.95 Million | CN¥96.95 Million | CN¥- | CN¥1.76 Billion | ▼ -270.1 pp |
| 2014 | 275.6% | CN¥849.99 Million | CN¥849.99 Million | CN¥- | CN¥308.44 Million | ▼ -1229.1 pp |
| 2013 | 1504.7% | CN¥752.85 Million | CN¥752.85 Million | CN¥- | CN¥50.03 Million | ▲ +1441.7 pp |
| 2012 | 63.0% | CN¥1.36 Billion | CN¥1.36 Billion | CN¥- | CN¥2.15 Billion | ▲ +9.5 pp |
| 2011 | 53.4% | CN¥1.24 Billion | CN¥1.24 Billion | CN¥- | CN¥2.32 Billion | ▲ +27.6 pp |
| 2005 | 25.8% | CN¥84.47 Million | CN¥84.47 Million | CN¥- | CN¥327.77 Million | ▼ -11.9 pp |
| 2004 | 37.6% | CN¥184.25 Million | CN¥184.25 Million | CN¥- | CN¥489.71 Million | ▼ -67.3 pp |
| 2003 | 104.9% | CN¥410.94 Million | CN¥410.94 Million | CN¥- | CN¥391.64 Million | ▲ +48.4 pp |
| 2002 | 56.5% | CN¥198.82 Million | CN¥198.82 Million | CN¥- | CN¥351.79 Million | ▲ +11.6 pp |
| 2001 | 44.9% | CN¥150.04 Million | CN¥150.04 Million | CN¥- | CN¥333.98 Million | ▼ -52.4 pp |
| 2000 | 97.3% | CN¥114.59 Million | CN¥114.59 Million | CN¥- | CN¥117.80 Million | — |